Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-gated calcium channel α2δ-2 subunit is an auxiliary subunit of voltage-gated calcium channels, crucial for modulating channel trafficking, surface expression, and biophysical properties. It enhances calcium current density, modifies channel kinetics, and plays a role in synaptic transmission and neurotransmitter release. Dysregulation is implicated in neurological disorders such as ataxia, epilepsy, and neuropathic pain. It is the target of drugs like gabapentin and pregabalin.
Binding to the α2δ subunit of voltage-gated calcium channels, decreasing calcium influx and reducing the release of excitatory neurotransmitters
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel alpha-two delta-two subunit (α2δ-2).